Showing 1 to 2 of 2 results


Pharmaceutical Industry Faces 2025 Inflection Point Amidst Global Cost Pressures
Global pharmaceutical manufacturers face increasing pressure to lower drug prices in 2025 due to government regulations (e.g., the Inflation Reduction Act), payer consolidation, and consumer cost concerns; requiring manufacturers to prioritize long-term value, evidence-based decision-making, and str...
Pharmaceutical Industry Faces 2025 Inflection Point Amidst Global Cost Pressures
Global pharmaceutical manufacturers face increasing pressure to lower drug prices in 2025 due to government regulations (e.g., the Inflation Reduction Act), payer consolidation, and consumer cost concerns; requiring manufacturers to prioritize long-term value, evidence-based decision-making, and str...
Progress
44% Bias Score

Corporate Sustainability: Navigating Policy Shifts
Recent policy shifts in the US and EU regarding corporate sustainability, including potential delays to the EU Deforestation Regulation and a possible consolidation of EU sustainability instruments, are creating uncertainty; however, businesses are likely to continue investing in sustainability due ...

Corporate Sustainability: Navigating Policy Shifts
Recent policy shifts in the US and EU regarding corporate sustainability, including potential delays to the EU Deforestation Regulation and a possible consolidation of EU sustainability instruments, are creating uncertainty; however, businesses are likely to continue investing in sustainability due ...
Progress
28% Bias Score
Showing 1 to 2 of 2 results